The PI3 Kinase Signaling Pathway in Prostate Cancer

被引：0
|
作者：
Elfiky, Aymen A. [1 ]
Jiang, Zhenyang [1 ]
机构：
[1] Harvard Univ, Sch Med, Dana Farber Canc Inst, Lank Ctr Genitourinary Oncol, Boston, MA 02115 USA
来源：
CURRENT CANCER DRUG TARGETS | 2013年 / 13卷 / 02期
关键词：
Androgen receptor; mammalian target of rapamycin; phosphatidylinositol; 3-kinase; prostate cancer; PTEN; ANDROGEN RECEPTOR FUNCTION; PTEN GENOMIC DELETION; 4-PHOSPHATASE TYPE-II; TRANSCRIPTION FACTORS; TUMOR-SUPPRESSOR; HORMONAL-THERAPY; CELL-POPULATIONS; FISH ANALYSIS; MTOR COMPLEX; GENE FUSIONS;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Despite recent advances in our understanding of the biological basis of prostate cancer, the management of the disease, especially in the castration-resistant phase, remains a significant challenge. Deregulation of the phosphatidylinositol 3-kinase (PI3K) pathway is increasingly implicated in a number of malignancies, including prostate carcinogenesis. In this review, we detail the role of this pathway in the pathogenesis of prostate cancer and the therapeutic implications of targeting it.
引用
收藏
页码：157 / 164
页数：8
相关论文
共 50 条
  • [21] The role of microRNAs involved in PI3-kinase signaling pathway in colorectal cancer
    Noorolyai, Saeed
    Mokhtarzadeh, Ahad
    Baghbani, Elham
    Asadi, Milad
    Kojabad, Amir Baghbanzadeh
    Mogaddam, Mahsa Maleki
    Baradaran, Behzad
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (05) : 5664 - 5673
  • [22] PI3K-AKT-mTOR signaling in prostate cancer progression and androgen deprivation therapy resistance
    Edlind, Merritt P.
    Hsieh, Andrew C.
    ASIAN JOURNAL OF ANDROLOGY, 2014, 16 (03) : 378 - 386
  • [23] Targeting PI3K/AKT/mTOR Signaling Pathway in Breast Cancer
    Li, Huayi
    Prever, Lorenzo
    Hirsch, Emilio
    Gulluni, Federico
    CANCERS, 2021, 13 (14)
  • [24] Heregulin-ErbB3-Driven Tumor Growth Persists in PI3 Kinase Mutant Cancer Cells
    Yarar, Defne
    Lahdenranta, Johanna
    Kubasek, William
    Nielsen, Ulrik B.
    MacBeath, Gavin
    MOLECULAR CANCER THERAPEUTICS, 2015, 14 (09) : 2072 - 2080
  • [25] Signalling downstream of PI3 kinase in mammary epithelium: a play in 3 Akts
    Wickenden, Julie A.
    Watson, Christine J.
    BREAST CANCER RESEARCH, 2010, 12 (02):
  • [26] Genetic Alterations in the PI3K Pathway in Prostate Cancer
    Sun, Xiuju
    Huang, Jian
    Homma, Taku
    Kita, Daisuke
    Klocker, Helmut
    Schafer, Georg
    Boyle, Peter
    Ohgaki, Hiroko
    ANTICANCER RESEARCH, 2009, 29 (05) : 1739 - 1743
  • [27] The PI3K/AKT pathway in the pathogenesis of prostate cancer
    Chen, Huixing
    Zhou, Lan
    Wu, Xiaorong
    Li, Rongbing
    Wen, Jiling
    Sha, Jianjun
    Wen, Xiaofei
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2016, 21 : 1084 - 1091
  • [28] PI3 kinase function is vital for the function but not formation of LAT-mediated signaling complexes
    Cruz-Orcutt, Noemi
    Houtman, Jon C. D.
    MOLECULAR IMMUNOLOGY, 2009, 46 (11-12) : 2274 - 2283
  • [29] Targeting the PI3K signaling pathway in cancer therapy
    Bartholomeusz, Chandra
    Gonzalez-Angulo, Ana Maria
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2012, 16 (01) : 121 - 130
  • [30] PI3 Kinase inhibition on TRAIL-induced apoptosis correlates with androgen-sensitivity and p21 expression in prostate cancer cells
    Yoshihiko Kadowaki
    Nikhil S. Chari
    Albert E. K. Teo
    Akihiko Hashi
    Kevin B. Spurgers
    Timothy J. McDonnell
    Apoptosis, 2011, 16 : 627 - 635
12345